Electrophysiological Evaluation of Post-Activation Potentiation/Post-Activation Performance Enhancement Using Strength-Duration Properties
Journal of Functional Morphology and Kinesiology · 2026-05-09 · 11 (2) · 188
DOI: 10.3390/jfmk11020188 ↗At a glance
Journal article in Journal of Functional Morphology and Kinesiology, published online on 2026-05-09. Written by Philip Gallardo and 3 co-authors. Institution: ErgoMechLab, Department of Physical Education and Sport Science, University of Thessaly, 421 00 Trikala, Greece. 103 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Strength-Duration (S-D) assessment is commonly used in clinics to examine the excitability of peripheral nerves and muscles. Yet, how changes in neuromuscular excitability relate to improved athletic and muscular performance in healthy subjects remains poorly understood. Therefore, the aim of the study was to evaluate the electrophysiological changes in neuromuscular excitability in the vastus medialis (VM) muscle using the S-D assessment, following a back squat conditioning activity (BS-CA) protocol designed to elicit a post-activation potentiation (PAP)/post-activation performance enhancement (PAPE) effect in healthy athletic males.
Methods
Eleven male physical education students were included in this study. All subjects performed two trials: one examining their BS one-repetition maximum (1-RM), and a main experiment. During the main experiment, baseline levels of rectangular rheobase (R-RIC), triangular rheobase (R-DIC), and chronaxie were collected from the VM muscle following a standard warmup. Subsequently, the subjects performed four warmup BS sets and executed a top set of five repetitions (reps) at 80% of 1-RM. Afterwards, R-RIC, R-DIC, and chronaxie were reassessed for pre and post analysis. Based on these S-D curve (SDC) parameters, the muscle adjustability quotient (MAQ) and threshold charge (Q) were also computed and compared.
Results
The R-RIC, R-DIC and Q were all significantly higher following the BS-CA, compared to pre-intervention (p < 0.001). No significant differences were observed for the chronaxie and MAQ (p > 0.05), although an increasing trend was noted for the chronaxie (p = 0.054).
Conclusions
Based on the findings from this study, the neuromuscular excitability in the VM muscle can be acutely altered following a BS-CA protocol. However, these changes seem to be more related to muscle fatigue than PAP/PAPE. Nevertheless, S-D assessment may broaden our understanding of the fatigue process during exercise.
Subjects
Author keywords
Authors and institutions
- ErgoMechLab, Department of Physical Education and Sport Science, University of Thessaly, 421 00 Trikala, Greece.
- Department Molecular Medicine and Surgery, Karolinska Institute, 171 76 Solna, Sweden.
- TC for Safety and Health, International Ergonomics Association (IEA), P.O. Box 1226 Geneva, Switzerland.
ORCID profiles: Philip Gallardo, Antonios Papageorgiou, Vasileios Tsagkogiannis, Panagiotis V Tsaklis
Cite
APA
Gallardo, P., Papageorgiou, A., Tsagkogiannis, V., & Tsaklis, P. V. (2026). Electrophysiological Evaluation of Post-Activation Potentiation/Post-Activation Performance Enhancement Using Strength-Duration Properties. Journal of Functional Morphology and Kinesiology, 11(2), 188. https://doi.org/10.3390/jfmk11020188
Vancouver
Gallardo P, Papageorgiou A, Tsagkogiannis V, Tsaklis PV. Electrophysiological Evaluation of Post-Activation Potentiation/Post-Activation Performance Enhancement Using Strength-Duration Properties. Journal of Functional Morphology and Kinesiology. 2026;11(2):188. doi:10.3390/jfmk11020188
BibTeX
@article{Gallardo2026,
author = {Gallardo, Philip and Papageorgiou, Antonios and Tsagkogiannis, Vasileios and Tsaklis, Panagiotis V},
title = {Electrophysiological Evaluation of Post-Activation Potentiation/Post-Activation Performance Enhancement Using Strength-Duration Properties},
journal = {Journal of Functional Morphology and Kinesiology},
year = {2026},
volume = {11},
number = {2},
pages = {188},
doi = {10.3390/jfmk11020188}
}
EUVIMED